Cargando…
PET tracer development—a tale of mice and men
PET scanning is an emerging technology for the clinical evaluation of many disease processes in man. The vast majority of clinical positron emission tomography (PET) studies are performed using a single tracer, fluorodeoxyglucose. Despite the excellent diagnostic performance of this tracer, it has r...
Autores principales: | Hicks, Rodney J, Dorow, Donna, Roselt, Peter |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
e-MED
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1805077/ https://www.ncbi.nlm.nih.gov/pubmed/17114061 http://dx.doi.org/10.1102/1470-7330.2006.9098 |
Ejemplares similares
-
Beyond FDG: novel PET tracers for cancer imaging
por: Hicks, Rodney J
Publicado: (2003) -
Rapid kit-based (68)Ga-labelling and PET imaging with THP-Tyr(3)-octreotate: a preliminary comparison with DOTA-Tyr(3)-octreotate
por: Ma, Michelle T., et al.
Publicado: (2015) -
How we read: the combined use of MRI and novel PET tracers for the characterisation and treatment planning of masses in neuro-oncology
por: Lasocki, Arian, et al.
Publicado: (2019) -
Plasma radio-metabolite analysis of PET tracers for dynamic PET imaging: TLC and autoradiography
por: Li, Fiona, et al.
Publicado: (2020) -
Update on PET Tracer Development for Muscarinic Acetylcholine Receptors
por: Ozenil, Marius, et al.
Publicado: (2021)